Nortech Systems to Report Third Quarter Results November 2
Quarterly Conference Call November 3 at 10:00 a.m. (CDT) 866-320-0174
MINNEAPOLIS--(BUSINESS WIRE)-- Nortech Systems Incorporated (NASDAQ: NSYS) announces a conference call to be held at 10:00 a.m. (CDT) on Thursday, November 3, 2016, to discuss the company’s third quarter 2016 results, which will be released after the market closes on November 2. Anyone interested in participating in the conference can access the call by dialing 866-320-0174 from within the United States, or 785-424-1631 if calling internationally. An audio webcast and replay of this conference call can be accessed at the investor relations portion of Nortech’s website at www.nortechsys.com or at www.investorcalendar.com.
A podcast (MP3 download) will also be available. The telephone replay will be available through November 17, 2016, by dialing 877-481-4010 (from U.S.) or 919-882-2331 (International). To access the replay, the conference ID 10126 is required.
Nortech Systems Incorporated (www.nortechsys.com), based in Maple Grove, Minn., is a full-service electronics manufacturing services (EMS) provider of wire and cable assemblies, printed circuit board assemblies and higher-level complete box build assemblies for a wide range of industries. Markets served include industrial equipment, aerospace/defense and medical. The company has operations in the U.S., Latin America and Asia. Nortech Systems Incorporated is traded on the NASDAQ Stock Market under the symbol NSYS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161026006925/en/
For Nortech Systems:
Brookside Communications Group
Warren
Djerf, 952-920-3908
[email protected]
Source: Nortech Systems Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
- MemeToro Presale News: Stage 7 Begins at $0.00430 as Funding Approaches $118.5K With Hundreds of New Buyers
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share